Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth

Gianfranco Alpini, Pietro Invernizzi, Eugenio Gaudio, Julie Venter, Shelleyko Kopriva, Francesca Bernuzzi, Paolo Onori, Antonio Franchitto, Monique Coufal, Gabriel Frampton, Domenico Alvaro, Sum P. Lee, Marco Marzioni, Antonio Benedetti, Sharon DeMorrow

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Cholangiocarcinoma is a devastating cancer of biliary origin with limited treatment options. Symptoms are usually evident after blockage of the bile duct by the tumor, and at this late stage, they are relatively resistant to chemotherapy and radiation therapy. Therefore, it is imperative that alternative treatment options are explored. We present novel data indicating that the metabolism of serotonin is dysregulated in cholangiocarcinoma cell lines, compared with normal cholangiocytes, and tissue and bile from cholangiocarcinoma patients. Specifically, there was an increased expression of tryptophan hydroxylase 1 and a suppression of monoamine oxidase A expression (enzymes responsible for the synthesis and degradation of serotonin, respectively) in cholangiocarcinoma. This resulted in an increased secretion of serotonin from cholangiocarcinoma and increased serotonin in the bile from cholangiocarcinoma patients. Increased local serotonin release may have implications on cholangiocarcinoma cell growth. Serotonin administration increased cholangiocarcinoma cell growth in vitro, whereas inhibition of serotonin synthesis decreases tumor cell growth both in vitro and in vivo. The data presented here represent the first evidence that serotonin metabolism is dysregulated in cholangiocarcinoma and that modulation of serotonin synthesis may represent an alternative target for the development of therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)9184-9193
Number of pages10
JournalCancer Research
Volume68
Issue number22
DOIs
StatePublished - Nov 15 2008
Externally publishedYes

Fingerprint

Cholangiocarcinoma
Serotonin
Growth
Neoplasms
Bile
Tryptophan Hydroxylase
Monoamine Oxidase
Bile Ducts
Radiotherapy
Therapeutics
Drug Therapy
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Alpini, G., Invernizzi, P., Gaudio, E., Venter, J., Kopriva, S., Bernuzzi, F., ... DeMorrow, S. (2008). Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Research, 68(22), 9184-9193. https://doi.org/10.1158/0008-5472.CAN-08-2133

Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. / Alpini, Gianfranco; Invernizzi, Pietro; Gaudio, Eugenio; Venter, Julie; Kopriva, Shelleyko; Bernuzzi, Francesca; Onori, Paolo; Franchitto, Antonio; Coufal, Monique; Frampton, Gabriel; Alvaro, Domenico; Lee, Sum P.; Marzioni, Marco; Benedetti, Antonio; DeMorrow, Sharon.

In: Cancer Research, Vol. 68, No. 22, 15.11.2008, p. 9184-9193.

Research output: Contribution to journalArticle

Alpini, G, Invernizzi, P, Gaudio, E, Venter, J, Kopriva, S, Bernuzzi, F, Onori, P, Franchitto, A, Coufal, M, Frampton, G, Alvaro, D, Lee, SP, Marzioni, M, Benedetti, A & DeMorrow, S 2008, 'Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth', Cancer Research, vol. 68, no. 22, pp. 9184-9193. https://doi.org/10.1158/0008-5472.CAN-08-2133
Alpini G, Invernizzi P, Gaudio E, Venter J, Kopriva S, Bernuzzi F et al. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Research. 2008 Nov 15;68(22):9184-9193. https://doi.org/10.1158/0008-5472.CAN-08-2133
Alpini, Gianfranco ; Invernizzi, Pietro ; Gaudio, Eugenio ; Venter, Julie ; Kopriva, Shelleyko ; Bernuzzi, Francesca ; Onori, Paolo ; Franchitto, Antonio ; Coufal, Monique ; Frampton, Gabriel ; Alvaro, Domenico ; Lee, Sum P. ; Marzioni, Marco ; Benedetti, Antonio ; DeMorrow, Sharon. / Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. In: Cancer Research. 2008 ; Vol. 68, No. 22. pp. 9184-9193.
@article{250b7ef5e44f4f379ec5f88fa47a5f90,
title = "Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth",
abstract = "Cholangiocarcinoma is a devastating cancer of biliary origin with limited treatment options. Symptoms are usually evident after blockage of the bile duct by the tumor, and at this late stage, they are relatively resistant to chemotherapy and radiation therapy. Therefore, it is imperative that alternative treatment options are explored. We present novel data indicating that the metabolism of serotonin is dysregulated in cholangiocarcinoma cell lines, compared with normal cholangiocytes, and tissue and bile from cholangiocarcinoma patients. Specifically, there was an increased expression of tryptophan hydroxylase 1 and a suppression of monoamine oxidase A expression (enzymes responsible for the synthesis and degradation of serotonin, respectively) in cholangiocarcinoma. This resulted in an increased secretion of serotonin from cholangiocarcinoma and increased serotonin in the bile from cholangiocarcinoma patients. Increased local serotonin release may have implications on cholangiocarcinoma cell growth. Serotonin administration increased cholangiocarcinoma cell growth in vitro, whereas inhibition of serotonin synthesis decreases tumor cell growth both in vitro and in vivo. The data presented here represent the first evidence that serotonin metabolism is dysregulated in cholangiocarcinoma and that modulation of serotonin synthesis may represent an alternative target for the development of therapeutic strategies.",
author = "Gianfranco Alpini and Pietro Invernizzi and Eugenio Gaudio and Julie Venter and Shelleyko Kopriva and Francesca Bernuzzi and Paolo Onori and Antonio Franchitto and Monique Coufal and Gabriel Frampton and Domenico Alvaro and Lee, {Sum P.} and Marco Marzioni and Antonio Benedetti and Sharon DeMorrow",
year = "2008",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-08-2133",
language = "English (US)",
volume = "68",
pages = "9184--9193",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth

AU - Alpini, Gianfranco

AU - Invernizzi, Pietro

AU - Gaudio, Eugenio

AU - Venter, Julie

AU - Kopriva, Shelleyko

AU - Bernuzzi, Francesca

AU - Onori, Paolo

AU - Franchitto, Antonio

AU - Coufal, Monique

AU - Frampton, Gabriel

AU - Alvaro, Domenico

AU - Lee, Sum P.

AU - Marzioni, Marco

AU - Benedetti, Antonio

AU - DeMorrow, Sharon

PY - 2008/11/15

Y1 - 2008/11/15

N2 - Cholangiocarcinoma is a devastating cancer of biliary origin with limited treatment options. Symptoms are usually evident after blockage of the bile duct by the tumor, and at this late stage, they are relatively resistant to chemotherapy and radiation therapy. Therefore, it is imperative that alternative treatment options are explored. We present novel data indicating that the metabolism of serotonin is dysregulated in cholangiocarcinoma cell lines, compared with normal cholangiocytes, and tissue and bile from cholangiocarcinoma patients. Specifically, there was an increased expression of tryptophan hydroxylase 1 and a suppression of monoamine oxidase A expression (enzymes responsible for the synthesis and degradation of serotonin, respectively) in cholangiocarcinoma. This resulted in an increased secretion of serotonin from cholangiocarcinoma and increased serotonin in the bile from cholangiocarcinoma patients. Increased local serotonin release may have implications on cholangiocarcinoma cell growth. Serotonin administration increased cholangiocarcinoma cell growth in vitro, whereas inhibition of serotonin synthesis decreases tumor cell growth both in vitro and in vivo. The data presented here represent the first evidence that serotonin metabolism is dysregulated in cholangiocarcinoma and that modulation of serotonin synthesis may represent an alternative target for the development of therapeutic strategies.

AB - Cholangiocarcinoma is a devastating cancer of biliary origin with limited treatment options. Symptoms are usually evident after blockage of the bile duct by the tumor, and at this late stage, they are relatively resistant to chemotherapy and radiation therapy. Therefore, it is imperative that alternative treatment options are explored. We present novel data indicating that the metabolism of serotonin is dysregulated in cholangiocarcinoma cell lines, compared with normal cholangiocytes, and tissue and bile from cholangiocarcinoma patients. Specifically, there was an increased expression of tryptophan hydroxylase 1 and a suppression of monoamine oxidase A expression (enzymes responsible for the synthesis and degradation of serotonin, respectively) in cholangiocarcinoma. This resulted in an increased secretion of serotonin from cholangiocarcinoma and increased serotonin in the bile from cholangiocarcinoma patients. Increased local serotonin release may have implications on cholangiocarcinoma cell growth. Serotonin administration increased cholangiocarcinoma cell growth in vitro, whereas inhibition of serotonin synthesis decreases tumor cell growth both in vitro and in vivo. The data presented here represent the first evidence that serotonin metabolism is dysregulated in cholangiocarcinoma and that modulation of serotonin synthesis may represent an alternative target for the development of therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=56449096956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449096956&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-2133

DO - 10.1158/0008-5472.CAN-08-2133

M3 - Article

C2 - 19010890

AN - SCOPUS:56449096956

VL - 68

SP - 9184

EP - 9193

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 22

ER -